Literature DB >> 1848449

The interaction between aspartic acid 237 and lysine 358 in the lactose carrier of Escherichia coli.

S C King1, C L Hansen, T H Wilson.   

Abstract

The lacY from Escherichia coli strains 020 and AE43 have been cloned on plasmids which were designated p020-K358T and pAE43-D237N. These lacY mutants contain amino acid substitutions changing Lys-358 to Thr or Asp-237 to Asn, respectively. The charge neutralizing effect of each mutation is associated with a functional defect in melibiose transport which we exploited in order to isolate second site revertants to the melibiose-positive phenotype. Eleven melibiose-positive revertants of p020-K358T were isolated. All contained a second-site mutation converting Asp-237 to a neutral amino acid (8 to Asn, 1 to Gly, and 2 to Tyr). Twelve melibiose-positive revertants of pAE43-D237N were isolated. Two were second-site revertants converting Lys-358 to a neutrally Gln residue, while the remainder directly reverted Asn-237 to the wild-type Asp-237. We conclude that the functional intimate relationship between Asp-237 and Lys-358 suggests that these residues may be closely juxtaposed in three-dimensional space, possibly forming a 'charge-neutralizing' salt bridge.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848449     DOI: 10.1016/0005-2736(91)90390-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  Arg-52 in the melibiose carrier of Escherichia coli is important for cation-coupled sugar transport and participates in an intrahelical salt bridge.

Authors:  P J Franco; T H Wilson
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Projection structure and molecular architecture of OxlT, a bacterial membrane transporter.

Authors:  J A Heymann; R Sarker; T Hirai; D Shi; J L Milne; P C Maloney; S Subramaniam
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

3.  Structural model for 12-helix transporters belonging to the major facilitator superfamily.

Authors:  Teruhisa Hirai; Jürgen A W Heymann; Peter C Maloney; Sriram Subramaniam
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

4.  Deceleration of the E1P-E2P transition and ion transport by mutation of potentially salt bridge-forming residues Lys-791 and Glu-820 in gastric H+/K+-ATPase.

Authors:  Katharina L Dürr; Ina Seuffert; Thomas Friedrich
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

5.  Functional interactions between putative intramembrane charged residues in the lactose permease of Escherichia coli.

Authors:  M Sahin-Tóth; R L Dunten; A Gonzalez; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  Characterization of a chromosomally encoded, non-PTS metabolic pathway for sucrose utilization in Escherichia coli EC3132.

Authors:  J Bockmann; H Heuel; J W Lengeler
Journal:  Mol Gen Genet       Date:  1992-10

7.  Conservation of residues involved in sugar/H(+) symport by the sucrose permease of Escherichia coli relative to lactose permease.

Authors:  Viveka Vadyvaloo; Irina N Smirnova; Vladimir N Kasho; H Ronald Kaback
Journal:  J Mol Biol       Date:  2006-03-09       Impact factor: 5.469

8.  Amino acid substitution in the lactose carrier protein with the use of amber suppressors.

Authors:  A M Huang; J I Lee; S C King; T H Wilson
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

9.  Evidence for the transport of maltose by the sucrose permease, CscB, of Escherichia coli.

Authors:  Yang Peng; Sanath Kumar; Ricardo L Hernandez; Suzanna E Jones; Kathleen M Cadle; Kenneth P Smith; Manuel F Varela
Journal:  J Membr Biol       Date:  2009-03-18       Impact factor: 1.843

10.  Site-directed spin labeling and chemical crosslinking demonstrate that helix V is close to helices VII and VIII in the lactose permease of Escherichia coli.

Authors:  J Wu; J Voss; W L Hubbell; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.